Clinical Trial Credentialing for Stereotactic Radiosurgery and Radiotherapy of Brain Metastases: Recommendations From the TROG SRS Technical Working Group.
1/5 보강
The uptake of stereotactic radiosurgery (SRS) for the treatment of brain metastases (BM) has been rapid.
APA
Shakeshaft J, Lusk R, et al. (2026). Clinical Trial Credentialing for Stereotactic Radiosurgery and Radiotherapy of Brain Metastases: Recommendations From the TROG SRS Technical Working Group.. Journal of medical imaging and radiation oncology, 70(2), 226-236. https://doi.org/10.1111/1754-9485.70064
MLA
Shakeshaft J, et al.. "Clinical Trial Credentialing for Stereotactic Radiosurgery and Radiotherapy of Brain Metastases: Recommendations From the TROG SRS Technical Working Group.." Journal of medical imaging and radiation oncology, vol. 70, no. 2, 2026, pp. 226-236.
PMID
41528055 ↗
Abstract 한글 요약
The uptake of stereotactic radiosurgery (SRS) for the treatment of brain metastases (BM) has been rapid. SRS differs from other forms of radiation therapy in that large radiation doses are typically delivered with small margins for error and high dose heterogeneity. Geometric accuracy relies on the integrity of the entire treatment chain including patient immobilisation, imaging, treatment equipment and verification. Given this requirement for high fidelity geometric and dosimetric accuracy, credentialing for SRS within clinical trials requires special considerations. This process is further complicated by the range of treatment equipment that may be used to deliver SRS. The Trans-Tasman Radiation Oncology Group (TROG) SRS Technical Working Group was established to develop technical guidelines for SRS to BM in clinical trials in Australia, New Zealand and any other countries contributing to TROG recruitment. The panel comprised experts from Radiation Oncology, Medical Physics, Radiation Therapy and the TROG Quality Assurance (QA) team. These guidelines were developed collaboratively to assist trial management committees to formulate SRS credentialing and QA requirements appropriate for the clinical questions addressed by their trial.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.